Pillstats
Rx only · Tablet · Oral

Eslicarbazepine Acetate

Brands: Aptiom · Eslicarbazepine Acetate

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US36 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN03AF04
RxCUI (US)1482502
US makers9 labelers
Packages69
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 28 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.72$5.43$8.15$10.86Dec 2025Mar 2026Jul 2026
$8.419
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
9
Active US suppliers
36%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.8K18K26K35K2025 Q12025 Q22025 Q32025 Q42026 Q1
24K
Rx · 2026 Q1
1.2M
Units dispensed
-20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Jubilant Cadista Pharmaceuticals Inc.unknown13SUPPLYING
Torrent Pharmaceuticals Limitedunknown12SUPPLYING
Camber Pharmaceuticals, Inc.unknown10SUPPLYING
Sumitomo Pharma America, Inc.unknown8SUPPLYING
Apotex Corp.unknown8SUPPLYING
Dr.Reddy's laboratories Limitedunknown6SUPPLYING
Lupin Pharmaceuticals,Inc.unknown4SUPPLYING
Golden State Medical Supply, Inc.unknown4SUPPLYING
Ascend Laboratories, LLCunknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.